Pfizer Inc. Schedule 13D - MFIC Corporation

0000078003-05-000028.txt : 20120703 0000078003-05-000028.hdr.sgml : 20120703 20050202150119 ACCESSION NUMBER: 0000078003-05-000028 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050202 DATE AS OF CHANGE: 20050202 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MFIC CORP CENTRAL INDEX KEY: 0000723889 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY APPARATUS & FURNITURE [3821] IRS NUMBER: 042793022 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-35850 FILM NUMBER: 05569021 BUSINESS ADDRESS: STREET 1: 30 OSSIPEE RD STREET 2: P O BOX 9101 CITY: NEWTON STATE: MA ZIP: 02464-9101 BUSINESS PHONE: 6179695452 MAIL ADDRESS: STREET 1: 30 OSSIPEE ROAD STREET 2: P O BOX 9101 CITY: NEWTON STATE: MA ZIP: 02164-9101 FORMER COMPANY: FORMER CONFORMED NAME: MICROFLUIDICS INTERNATIONAL CORP DATE OF NAME CHANGE: 19930713 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125732323 MAIL ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 SC 13D 1 mfic13d.htm MFIC CORPORATION SCHEDULE 13D Pfizer Inc. Schedule 13D - MFIC Corporation

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 4)*

MFIC Corporation
(Name of Issuer)

Common Stock, par value $0.01 per share
(Title of Class of Securities)

595073 10 7
(CUSIP Number)

Margaret M. Foran
Vice President - Corporate Governance and Secretary
Pfizer Inc. 235 East 42nd Street
New York, New York 10017
( 212)-733-4802
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

December 31, 2004
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

_ Rule 13d-1(b)

x Rule 13d-1(c)

_ Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

CUSIP No. 595073 10 7.................................

1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)

G.D. Searle LLC;                                     36-3399885

2. Check the Appropriate Box if a Member of a Group (See Instructions)

(a)

(b)

3. SEC Use Only ........................................................................................

4. Source of Funds (See Instructions) ......WC..................................................

5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

6. Citizenship or Place of Organization - Delaware

Number of Shares Beneficially Owned by Each Reporting Person With:

7. Sole Voting Power.. 600,000............

8. Shared Voting Power

9. Sole Dispositive Power     600,000

10. Shared Dispositive Power ........................................................................................

11. Aggregate Amount Beneficially Owned by Each Reporting Person. 600,000.............

12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ...

13. Percent of Class Represented by Amount in Row (11) 6.1%

14. Type of Reporting Person (See Instructions) - CO .

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 4)*

MFIC Corporation
(Name of Issuer)

Common Stock, par value $0.01 per share
(Title of Class of Securities)

595073 10 7
(CUSIP Number)

December 31, 2004
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

_ Rule 13d-1(b)

x Rule 13d-1(c)

_ Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

CUSIP No. 595073 10 7...............................

15. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)

Pfizer, Inc. ;                                               13-5315170

16. Check the Appropriate Box if a Member of a Group (See Instructions)

(a)

(b)

17. SEC Use Only ........................................................................................

18. Source of Funds (See Instructions) ......WC..................................................

19. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

20. Citizenship or Place of Organization - Delaware

Number of Shares Beneficially Owned by Each Reporting Person With:

21. Sole Voting Power..                   0

22. Shared Voting Power

23. Sole Dispositive Power              0

24. Shared Dispositive Power

25. Aggregate Amount Beneficially Owned by Each Reporting Person. 600,000.............

26. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ...

27. Percent of Class Represented by Amount in Row (11)   6.1 %

28. Type of Reporting Person (See Instructions) - CO .

This Amendment No. 4 to the Statement on Schedule 13D filed by G.D. Searle & Co., a Delaware corporation and amended most recently on June 12, 2003, (the "Schedule 13D") relates to the Common Stock, $.01 par value, of MFIC Corporation (formerly Microfluidics International Corporation, "Issuer") and amends the Schedule 13D as follows:

1. Item 5(a) is amended to reflect the percent of class owned by purchaser of 6.1% based upon the number of shares of Issuer outstanding on December 31, 2004.

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

February 1, 2005
( Date)

Signature             /s/ Susan Grant
                          Susan Grant, G.D. Searle LLC-Secretary
                          ( Name/Title)